A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection

[Image: see text] As the Ebola outbreak in West Africa continues and cases appear in the United States and other countries, the need for long-lasting vaccines to preserve global health is imminent. Here, we evaluate the long-term efficacy of a respiratory and sublingual (SL) adenovirus-based vaccine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Pharm
Main Authors: Choi, Jin Huk, Jonsson-Schmunk, Kristina, Qiu, Xiangguo, Shedlock, Devon J., Strong, Jim, Xu, Jason X., Michie, Kelly L., Audet, Jonathan, Fernando, Lisa, Myers, Mark J., Weiner, David, Bajrovic, Irnela, Tran, Lilian Q., Wong, Gary, Bello, Alexander, Kobinger, Gary P., Schafer, Stephen C., Croyle, Maria A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2014
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525323/
https://ncbi.nlm.nih.gov/pubmed/25363619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp500646d
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados